Breaking
Bond Anchor
Author

admin

Browsing
Investing

Quimbaya Gold Announces C$10 Million Bought Deal Financing

/NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES./

Quimbaya Gold Inc. (‘Quimbaya’ or the ‘Company’) (CSE: QIM,OTC:QIMGF) (OTCQB: QIMGF) (FSE: K05) is pleased to announce that it has entered into an agreement with Stifel Canada to act as sole underwriter and bookrunner (the ‘Underwriter’), in connection with a ‘bought deal’ private placement of 14,300,000 units of the Company  (the ‘LIFE Units’) at a price of C$0.70 per LIFE Unit (the ‘Offering Price’) for aggregate gross proceeds of C$10,010,000 (the ‘Offering’), with the LIFE Units to be issued pursuant to the Listed Issuer Financing Exemption (as defined below). 

The Company has granted to the Underwriter an option, exercisable up to 48 hours prior to the closing date, to purchase for resale up to an additional 15% of LIFE Units at the Offering Price for additional gross proceeds of up to C$1,501,500. 

Each LIFE Unit will consist of one common share (a ‘Common Share‘) and one-half (½) of one Common Share purchase warrant (each whole warrant, a ‘Warrant‘) of the Company. Each Warrant will be exercisable to acquire one Common Share for a period of 36 months following the closing date of the Offering at an exercise price of C$1.00 per common share.

The net proceeds from the Offering are expected to be used to advance the Company’s exploration programs, including drilling at the Tahami South project and follow-up work on regional copper-gold and gold targets, as well as for general working capital.

Subject to compliance with applicable regulatory requirements and in accordance with National Instrument 45-106 – Prospectus Exemptions (‘NI 45-106‘), the LIFE Units will be offered for sale to purchasers resident in Canada other than Quebec and/or other qualifying jurisdictions pursuant to the listed issuer financing exemption under Part 5A of NI 45-106 (the ‘Listed Issuer Financing Exemption‘). Because the Offering is being completed pursuant to the Listed Issuer Financing Exemption, the LIFE Units issued pursuant to the Offering will not be subject to a hold period pursuant to applicable Canadian securities laws. There is an offering document related to the Offering that can be accessed under the Company’s issuer profile on SEDAR+ at www.sedarplus.ca and on the Company’s website at quimbayagold.com. Prospective investors should read the offering document before making an investment decision.

The Offering is scheduled to close on or about November 4, 2025 (the ‘Closing Date‘) and is subject to certain conditions including, but not limited to, the receipt of all necessary regulatory and other approvals including the acceptance of the Canadian Securities Exchange.

The securities referred to in this news release have not been and will not be registered under the United States Securities Act of 1933, as amended (the ‘U.S. Securities Act‘), or any state securities laws and may not be offered or sold within the United States or to, or for the account or benefit of, ‘U.S. Persons’ (as such term is defined in Regulation S under the U.S. Securities Act) absent such registration or an applicable exemption from the registration requirements of the U.S. Securities Act. This news release does not constitute an offer for sale of securities for sale, nor a solicitation for offers to buy any securities. Any public offering of securities in the United States must be made by means of a prospectus containing detailed information about the company and management, as well as financial statements.

About Quimbaya 

Quimbaya aims to discover gold resources through exploration and acquisition of mining properties in the prolific gold mining districts of Colombia. Managed by an experienced team in the mining sector, Quimbaya is focused on three projects in the regions of Segovia (Tahami Project), Puerto Berrio (Berrio Project), and Abejorral (Maitamac Project), all located in Antioquia Province, Colombia.

Quimbaya Gold Inc.

Follow on X @quimbayagoldinc
Follow on LinkedIn @quimbayagold
Follow on YouTube @quimbayagoldinc
Follow on Instagram @quimbayagoldinc
Follow on Facebook @quimbayagoldinc

Cautionary Statements

Certain statements contained in this press release constitute ‘forward-looking information’ as that term is defined in applicable Canadian securities legislation. All statements, other than statements of historical fact, included herein are forward-looking information. Generally, but not always, forward-looking statements and information can be identified by the use of forward-looking terminology such as ‘intends’, ‘expects’ or ‘anticipates’, or variations of such words and phrases or statements that certain actions, events or results ‘may’, ‘could’, ‘should’, ‘would’ or ‘occur’. Forward-looking statements herein include statements and information regarding the closing of the Offering, Offering’s intended use of proceeds, any exercise of Warrants, the future plans for the Company, including any expectations of growth or market momentum, future expectations for the gold sector generally, the Colombian gold sector more particularly, or how global or local market trends may affect the Company, intended exploration on any of the Company’s properties and any results thereof, the strength of the Company’s mineral property portfolio, the potential discovery and potential size of the discovery of minerals on any property of the Company’s, including Tahami South, the aims and goals of the Company, and other forward-looking information. Forward-looking information by its nature is based on assumptions and involves known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of Quimbaya to be materially different from any future results, performance or achievements expressed or implied by such forward-looking statements or information. These assumptions include, but are not limited to, that the Company’s exploration and other activities will proceed as expected. The future outcomes that relate to forward-looking statements may be influenced by many factors, including but not limited to: future planned development and other activities on the Company’s mineral properties; an inability to finance the Company; obtaining required permitting on the Company’s mineral properties in a timely manner; any adverse changes to the planned operations of the Company’s mineral properties; failure by the Company for any reason to undertake expected exploration programs; achieving and maintaining favourable relationships with local communities; mineral exploration results that are poorer or better than expected; prices for gold remaining as expected; currency exchange rates remaining as expected; availability of funds for the Company’s projects; prices for energy inputs, labour, materials, supplies and services (including transportation); no labour-related disruptions; no unplanned delays or interruptions in scheduled construction and production; all necessary permits, licenses and regulatory approvals are received in a timely manner; the Offering proceeds being received as anticipated; all requisite regulatory and stock exchange approvals for the Offering are obtained in a timely fashion; investor participation in the Offering; and the Company’s ability to comply with environmental, health and safety laws. Although Quimbaya’s management believes that the assumptions made and the expectations represented by such information are reasonable, there can be no assurance that the forward-looking information will prove to be accurate. Furthermore, should one or more of the risks, uncertainties or other factors materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in forward-looking statements or information. Readers are cautioned not to place undue reliance on forward-looking information as there can be no assurance that the plans, intentions or expectations upon which they are placed will occur. Forward-looking information contained in this news release is expressly qualified by this cautionary statement. The forward-looking information contained in this news release represents the expectations of Quimbaya as of the date of this news release and, accordingly, is subject to change after such date. Except as required by law, Quimbaya does not expect to update forward-looking statements and information continually as conditions change.

SOURCE Quimbaya Gold Inc.

View original content: http://www.newswire.ca/en/releases/archive/October2025/23/c7762.html

News Provided by Canada Newswire via QuoteMedia

This post appeared first on investingnews.com

Keep Reading
By
Investing

Top 4 Canadian Biotech Stocks of 2025

Biotech is a dynamic industry that is driving scientific advances and innovation in healthcare. In Canada, the biotech sector is home to companies pursuing cutting-edge therapies and medical technologies.

Read on to learn what’s been driving these Canadian biotech firms.

1. Eupraxia Pharmaceuticals (TSX:EPRX)

Year-on-year gain: 141.23 percent
Market cap: C$410.85 million
Share price: C$8.25

Eupraxia Pharmaceuticals is developing clinical candidates that employ its DiffuSphere technology, which delivers treatments to the targeted tissues.

The company’s candidates are currently EP-104GI for eosinophilic esophagitis and EP-104IAR for knee osteoarthritis, and it is exploring the use of its technology for other active compounds as well.

Eupraxia added EP-104GI to its pipeline through its acquisition of EpiPharma Therapeutics in late 2023. The company has continued to advance the treatment through clinical trials in 2025 and released multiple rounds of positive data from its Phase 1b/2a trial cohorts.

In July, Eupraxia dosed its first patient after advancing its investigation to Phase 2b trials based on safety and efficacy data from the earlier Phase 2a patient cohorts. Top-line results from the Phase 2b study are anticipated in the second half of 2026.

In September, the company shared data from the highest-dose cohort of the still ongoing Phase 1b/2a trials, reporting that the group saw the largest improvements so far.

2. Bright Minds Biosciences (CSE:DRUG)

Year-on-year gain: 103.17 percent
Market cap: C$683.67 million
Share price: C$92.95

Bright Minds Biosciences is developing novel serotonin agonists targeting neurocircuit abnormalities linked to neuropsychiatric disorders and epilepsy, designing next-generation treatments that aim to retain the therapeutic benefits of psychedelics while minimizing side effects.

Its lead candidate, BMB-101, a selective 5-HT2C receptor agonist, has shown encouraging preclinical efficacy by stopping seizures in an epilepsy mouse model, evaluated jointly with Firefly Neuroscience (NASDAQ:AIFF).

The company’s stock surged nearly 1,500 percent in October 2024 following H. Lundbeck’s acquisition announcement of a competitor focused on similar targets. Strengthening its epilepsy expertise, Bright Minds expanded its scientific advisory board in early 2025 by adding five leaders in the field.

Ongoing clinical progress and strategic growth initiatives position Bright Minds as a promising contender in the neuropsychiatric treatment landscape.

3. Hemostemix (TSXV:HEM)

Year-on-year gain: 31.25 percent
Market cap: C$18.40 million
Share price: C$0.11

Hemostemix is a clinical-stage biotech company focused on developing autologous stem cell therapies, meaning the treatments use a patient’s own cells to theoretically enhance safety and efficacy.

Its main product, ACP-01, is an autologous cell therapy designed to promote tissue repair and regeneration in areas affected by diseases, including a range of heart diseases.

The company announced its first advanced sales orders for ACP-01 in Q1 2025 and has been working to expand internationally and attract new investment.

Hemostemix secured the regulatory green light for commercial sales in Florida after the state passed Senate Bill 1768. The bill creates a framework in which healthcare providers can administer stem cell therapies that had not yet been approved by the US Food and Drug Administration (FDA) but meet the bill’s guidelines.

The company now offers commercial ACP-01 treatments for ischemic pain in the state under the name VesCell, with sales forecasted to reach C$22.5 million in 2026. Operational plans target cash flow positivity by Q4 2026, supported by a growing physician network and commercial pipeline.

Additionally, Hemostemix is currently collaborating with Firefly Neuroscience on a Phase 1 clinical trial of ACP-01 for vascular dementia.

4. NervGen (TSXV:NGEN)

Year-on-year gain: 79.92 percent
Market cap: C$300.97 million
Share price: C$4.39

NervGen is a clinical-stage Canadian biotechnology company that focuses on developing innovative treatments to enable the nervous system to repair itself following damage from injury or disease.

The company’s core technology targets a mechanism that hinders nervous system repair. When the nervous system is damaged, chondroitin sulfate proteoglycans (CSPG) form a “scar.” Initially, CSPGs help contain damage, but their long-term interaction with the PTPσ receptor inhibits repair.

NervGen’s lead drug candidate, NVG-291, is designed to relieve these inhibitory effects to promote nervous system repair. It received fast-track designation from the US FDA.

NervGen is advancing NVG-291 in a Phase 1b/2a clinical trial for spinal cord injury (SCI) and reported positive data from the chronic cohort in June.

NVG-300, a newer preclinical candidate, is being evaluated for ischemic stroke and SCI.

Securities Disclosure: I, Meagen Seatter, hold no direct investment interest in any company mentioned in this article.

This post appeared first on investingnews.com

Keep Reading
By
Investing

Canadian Investment Regulatory Organization Trade Resumption – QIM

Trading resumes in:

Company: Quimbaya Gold Inc.

CSE Symbol: QIM

All Issues: Yes

Resumption (ET): 8:15 AM

CIRO can make a decision to impose a temporary suspension (halt) of trading in a security of a publicly-listed company. Trading halts are implemented to ensure a fair and orderly market. CIRO is the national self-regulatory organization which oversees all investment dealers and trading activity on debt and equity marketplaces in Canada.

SOURCE Canadian Investment Regulatory Organization (CIRO) – Halts/Resumptions

View original content: http://www.newswire.ca/en/releases/archive/October2025/24/c1478.html

News Provided by Canada Newswire via QuoteMedia

This post appeared first on investingnews.com

Keep Reading
By
Economy

Trump’s Argentina beef import plan will harm U.S. ranchers, industry warns

The American cattle ranching industry is blasting President Donald Trump’s proposal to purchase beef from Argentina in an effort to lower supermarket beef prices.

“This plan only creates chaos at a critical time of the year for American cattle producers, while doing nothing to lower grocery store prices,” Colin Woodall, CEO of the National Cattlemen’s Beef Association, said in a statement Monday.

Wyoming-based cattle operation Meriwether Farms addressed Trump directly in a social media post Monday.

“We love you and support you — but your suggestion to buy beef from Argentina to stabilize beef prices would be an absolute betrayal to the American cattle rancher,” the farm wrote on X.

By midday Tuesday, the post had already received 4 million views. A representative for Meriwether Farms did not immediately respond to a request for comment.

Trump floated purchasing beef from the South American nation Sunday aboard Air Force One to push down U.S. beef prices by increasing the overall supply.

‘We would buy some beef from Argentina,’ he told reporters, ‘If we do that, that will bring our beef prices down.’

Beef prices have hit record highs this year, according to data from the Bureau of Labor Statistics, fueled in part by depleted herd counts and steady demand from U.S. consumers.

This post appeared first on NBC NEWS

Keep Reading
By
Economy

Travis Kelce part of investor group aiming to revive struggling Six Flags

A group that includes activist investor Jana Partners and NFL player Travis Kelce says it has accumulated one of the largest ownership stakes in Six Flags Entertainment and intends to press the company’s leadership on ways to improve the struggling amusement park operator’s business.

Jana said Tuesday that the investor group now owns an economic interest of approximately 9% in Six Flags. The group plans to ‘engage’ with Six Flags’ management and board of directors to discuss ways to enhance shareholder value and improve visitors’ experience.

Shares in the Charlotte, North Carolina-based Six Flags surged 17.7% on the news. The shares added another 5.1% gain in after-hours trading. Even with Tuesday’s rally, the company’s shares are down about 47% so far this year.

Six Flags reported a loss of $319.4 million for the first half of the year. The company said attendance fell 9% in the three months that ended June 29, due partly to bad weather and a ‘challenged consumer’ in most of the markets it operates in.

The investor group also includes consumer executive Glenn Murphy and technology executive Dave Habiger.

Kelce, tight end for the Kansas City Chiefs, said in a statement that he grew up going to Six Flags amusement parks.

‘The chance to help make Six Flags special for the next generation is one I couldn’t pass up,’ he said.

This post appeared first on NBC NEWS

Keep Reading
By
Economy

X-ray tables, hidden cameras: The tech in rigged poker games linked to the mob and NBA

Card-reading contact lenses, X-ray poker tables, trays of poker chips that read cards, hacked shuffling machines that predict hands. The technology alleged to have been used to execute a multistate, rigged poker operation sounds like it’s straight out of Hollywood.

And those were only some of the gadgets that authorities say were used to swindle millions of dollars from unsuspecting victims through rigged, high-dollar, underground poker games over more than five years.

A sprawling indictment unsealed Thursday by the U.S. attorney for the Eastern District of New York charged Chauncey Billups, the head coach of the NBA’s Portland Trail Blazers, and Damon Jones, a former NBA player, along with members of the Mafia and dozens of other defendants, with being part of a conspiracy.

The victims were “at the mercy of concealed technology, including rigged shuffling machines and specially designed contacts lenses and sunglasses to read the backs of playing cards, which ensured that the victims would lose big,” U.S. Attorney Joseph Nocella of Brooklyn said in a statement.

Cheating at poker is as old as poker itself. But today, wearable tech and nano-cameras are putting even upstanding poker players on their guard.

The defendants used “special contact lenses or eyeglasses that could read pre-marked cards,” Nocella said at a news conference announcing the indictments.

He also showed a photo of an X-ray table that “could read cards face down on the table … because of the X-ray technology.”

An X-ray poker table in an image from defendant Robert Stroud’s iCloud account.U.S. Justice Department

“Defendants used other cheating technologies, such as poker chip tray analyzers, which is a poker chip tray that secretly reads cards using a hidden camera,” he said.

And while marking poker cards so they are visible only with special eyewear is an old trick, new radio-frequency identification and infrared technologies have ramped up the sophistication levels.

Technically speaking, many of the devices involved in the alleged scam authorities detailed Thursday are relatively cheap to manufacture, said Sal Piacente, a gaming security consultant.

By the time they reach their customers, however, the cost of industrial shufflers or tables can easily approach $100,000, once distributors and middlemen are factored in.

“You could make a lucrative career buying this stuff,” Piacente said.

Casino and gaming security consultants told NBC News that the alleged scheme was possible only because the games were underground. In backrooms, there was none of the surveillance tech that reputable casinos use to catch players cheating.

“A lot of the features which made this scheme so successful would have been ID’d a lot sooner, or very quickly, in a traditional regulated gaming environment,” said Ian Messenger, a former U.K. law enforcement officer and founder and CEO of the Association of Certified Gaming Compliance Specialists.

More than any other tech, it was the reprogramming of the industrial card shufflers — identified in charging documents as Deckmate-brand machines — that authorities said was key to the alleged game rigging.

A DeckMate 2 shuffler taken apart on a table in an image from defendant Shane Hennen’s iCloud account. U.S. Justice Department

Deckmates are not sold directly to the public — though many used ones can be found for sale online. The ones at the high-dollar games cited in the indictment could read cards and predict which player had the best hand. Neither Deckmate nor its parent company, Light & Wonder, were implicated in any way in Thursday’s indictments.

A spokesman for Light & Wonder told NBC News in a statement that the company was aware of reports about the charges against people but said they were not affiliated with the company.

“We sell and lease our automatic card shufflers and other gaming products and services only to licensed casinos and other licensed gaming establishments,” said Andy Fouché, the company’s vice president of communications. “We will cooperate in any law enforcement investigation related to this indictment.”

Reprogramming shufflers is not a new trick. In 2023, hackers at the Black Hat security conference in Las Vegas presented research showing how to hack a Deckmate shuffler and use it to cheat.

The rigged shuffler machines would transmit information about the players’ hands to an off-site “operator,” according to prosecutors.

The computer program showing information transmitted by the rigged shuffling machine in an image from defendant Shane Hennen’s iCloud account. U.S. Justice Department

The operator would then communicate the information to someone else at the table, dubbed the “quarterback.” The victim was known as the “fish.”

Here, the high-tech gadgets met the low-tech of a card game.

The quarterback might touch the $1,000 poker chip or tap his chin or touch his black chips to indicate who at the table had the best hand.

Text messages obtained by prosecutors also appear to show defendants concerned that a fish would leave the table if he lost too many hands.

“Guys please let him win a hand he’s in for 40k in 40 minutes he will leave if he gets no traction,” read one text message released by authorities.

But according to Messenger, the consultant, it was not the tech that made the alleged scheme so successful for so long. What set it apart was the level of communication.

For example, he said, the card information had to be seamlessly passed from the dealing machines to an off-site operator and back to a person back at the table, all without alerting the fish.

“The piece that made this so successful was the coordination, not the technology,” he said.

This post appeared first on NBC NEWS

Keep Reading
By
Politics

Trump meets NATO’s Rutte amid canceled Putin meeting: ‘It didn’t feel right to me’

President Donald Trump met with NATO Secretary-General Mark Rutte Wednesday — days after Ukrainian President Volodymyr Zelenskyy visited the White House andafter calling off a meeting with Russian President Vladimir Putin.

‘We canceled the meeting with President Putin,’ Trump told reporters in the Oval Office with Rutte Wednesday. ‘It just it didn’t feel right to me. It didn’t feel like we were going to get to the place we have to get. So I canceled it. But we’ll do it in the future.’ 

Trump also shed insight into why he isn’t interested in arming Ukraine with Tomahawk missiles, after indicating earlier in October he might do so. 

‘There is a tremendous learning curve with the Tomahawk. It’s a very powerful weapon, very accurate weapon,’ Trump said. ‘And maybe that’s what makes it so complex. But it will take a year. It takes a year of intense training to learn how to use it, and we know how to use it. And we’re not going to be teaching other people. It will be just too far out into the future.’ 

Rutte said he visited the White House to discuss ways to end the war, although he said ‘no peace plan is on the table.’ 

‘That’s why I’m here — to dialog again with the president … how NATO, my colleagues and other colleagues in NATO can be of maximum support to get that,’ Rutte said. 

NATO announced Tuesday that Rutte would visit Washington Wednesday, as Trump has said he wants to direct his focus on ending the conflict between Russia and Ukraine following the ceasefire deal in the Middle East. 

Ahead of his arrival at the White House, Rutte said that Wednesday’s White House visit aimed to build on the momentum after securing the peace agreement in the Middle East. 

‘I was texting with the president after an enormous success in Gaza, and we said, ‘Hey, let’s have a meeting in Washington to discuss how we now can deliver his vision of peace in Ukraine,’’ Rutte told reporters on Capitol Hill Wednesday after meeting with lawmakers, according to The New York Times.

‘I have total confidence in President Trump. He’s the only one who can get this done,’ Rutte said. 

Rutte has visited the White House on several occasions during Trump’s second term, including in July and also in August after Trump’s Alaska summit with Putin. NATO has backed Ukraine since Russia first invaded, and has provided Kyiv with military equipment and other assistance since 2022. 

In August, Rutte and other European leaders joined Zelenskyy in an effort to advance peace talks to end the war in Ukraine. At the time, Trump said that European nations would shoulder the bulk of the burden by providing Ukraine with security guarantees in an attempt to deter future aggression from Russia. 

As part of these security guarantees, Ukraine has sought to become a member of NATO during the peace negotiations. However, Trump has routinely ruled that out as a possibility. 

Meanwhile, Russia’s list of demands has historically included prohibiting Ukraine from ever joining NATO, and concessions on some land that previously belonged to Kyiv. 

Additionally, Rutte’s meeting comes after Trump appeared to throw cold water on any hopes that the U.S. would arm Ukraine with Tomahawk missiles, like Trump had said he was considering doing days ahead of Zelenskyy’s visit. 

‘I would much rather have them not need Tomahawks,’ Trump told reporters Friday. ‘I would much rather have the war be over to be honest, because we’re in it to get the war over.’ 

Additionally, Trump changed his tune on whether Ukraine would need to cede territory it had lost to Russia as part of a peace deal. Although Trump altered his position in September and said that Ukraine could secure back its lost territory, Trump reverted to his previously held position on the matter. 

‘They can negotiate something later on down the line,’ Trump told reporters Sunday. ‘But I said cut and stop at the battle line. Go home. Stop fighting, stop killing people.’

The change in tone came after Trump spoke with Putin Thursday and the two were originally slated to meet this month in Budapest. However, plans for the meeting were scrapped after Secretary of State Marco Rubio’s call with Russian Foreign Minister Sergey Lavrov. 

‘Secretary Rubio and Foreign Minister Lavrov had a productive call,’ a senior official said in a statement Tuesday to Fox News. ‘Therefore an additional in-person meeting between the Secretary and Foreign Minister is not necessary and there are no plans for President Trump to meet with President Putin in the near future.’ 

Meanwhile, Trump has recently cast doubt on whether Ukraine can defeat Russia. 

‘They could still win it. I don’t think they will, but they could still win it,’ Trump told reporters Monday. 

Fox News’ Gillian Turner and The Associated Press contributed to this report. 

This post appeared first on FOX NEWS

Keep Reading
By
Politics

FLASHBACK: Ted Cruz predicts ballooning Obamacare subsidies now at center of shutdown fight

Over a decade ago, Sen. Ted Cruz, R-Texas, predicted that healthcare premiums would skyrocket, even in the face of subsidies put into effect under Obamacare that were meant to bring them down. 

Today, the ballooning of those premiums and their accompanying subsidies are at the center of the 22-day shutdown that looks poised to get longer still.

‘Despite Obamacare subsidies, many Americans will still be paying higher premiums in 2014 as a result of Obamacare,’ Cruz said in 2013, referring to the Affordable Care Act (ACA).

In his 2013 floor speech, Cruz pointed to research from Avik Roy, a healthcare researcher who, at the time, was a senior fellow at the Manhattan Institute. Roy’s research made the case that subsidies passed by the Obama administration would do little to stop government-backed healthcare plans from growing more expensive over time or competing effectively with non-government-backed plans. 

But even those forecasts have paled in comparison to the costs of the government’s emergency response to the COVID-19 pandemic.

The subsidies under Obamacare have vastly expanded in recent years. An emergency provision included in President Joe Biden’s 2021 American Rescue Plan widened the range of eligible applicants as a response to the global pandemic. 

Now that those COVID-era provisions are set to sunset at the end of 2025, an expiration date set by Democrats themselves, Democrats are voicing alarm that Obamacare policyholders will have to shoulder the costs of health insurance without the enhanced supplemental aid. 

According to the Committee for a Responsible Federal Budget, a nonpartisan think tank that focuses on fiscal policy, continuing the expanded credits could cost upwards of $30 billion annually. Findings by KFF, a healthcare policy group, say that over 90% of the 24 million Obamacare enrollees make use of the enhanced credits.

KFF analysis indicates that the enhanced premium tax credits saved subsidized enrollees an average of $705 last year. 

Democrats in Congress, led by House Minority Leader Hakeem Jeffries, D-N.Y., and Senate Minority Leader Chuck Schumer, D-N.Y., have demanded some sort of extension to the already expanded COVID-era subsidies as a condition for passing spending legislation to end the current government shutdown, which is now the longest full shutdown in history.

Republicans, who maintain that the subsidies are completely unrelated to government funding considerations, have said lawmakers will address the subsidies when the government is open again.

The most conservative members in Congress have said cutting back on the subsidies is key to returning the government to pre-COVID levels of funding.

Lawmakers in the Senate have voted 11 times on a short-term spending extension meant to keep the government open through Nov. 21 but have so far failed to move past the gridlock over the enhanced premium tax credits.

Cruz did not immediately respond to Fox News Digital’s request for comment.

This post appeared first on FOX NEWS

Keep Reading
By